Clinical Trial Update: Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating a chemopreventive regimen combining an EGFR inhibitor and a COX-2 inhibitor in precancerous conditions; the study completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Precancerous Conditions

Drugs mentioned

• EGFR and COX-2 inhibitor (combination)

Snippet

Sponsor: Emory University | Conditions: Precancerous Conditions | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-10-24